Literature DB >> 30532839

Risk stratification for sudden cardiac death after septal myectomy.

Richard D Rothman1, Muhamad A Safiia1, Patricia A Lowry1, Theofanie Mela1, Suhny Abbara1, Caitlin O'Callaghan1, Eugene J Mark1, Gus J Vlahakes1, Michael A Fifer1.   

Abstract

BACKGROUND: The importance of risk stratification for sudden cardiac death (SCD) after septal myectomy for hypertrophic obstructive cardiomyopathy (HOCM) has not been emphasized previously. METHODS AND
RESULTS: We report 2 patients with SCD or ventricular tachycardia (VT) after septal myectomy for HOCM in whom risk factors for SCD were identified following surgical myectomy. One received an implantable cardioverter-defibrillator (ICD), which subsequently provided appropriate discharges for VT. The other delayed ICD implantation and suffered SCD.
CONCLUSION: These cases emphasize the importance of risk stratification for SCD after septal myectomy for HOCM.

Entities:  

Keywords:  Cardioverter-defibrillator; HOCM; Heart disease; Hypertrophic cardiomyopathy; Myectomy; Risk factors; Septal reduction therapy

Year:  2011        PMID: 30532839      PMCID: PMC6265092          DOI: 10.1016/j.jccase.2010.12.002

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  12 in total

Review 1.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

Review 2.  Management of symptoms in hypertrophic cardiomyopathy.

Authors:  Michael A Fifer; Gus J Vlahakes
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

3.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  Rory O'Hanlon; Agata Grasso; Michael Roughton; James C Moon; Susan Clark; Ricardo Wage; Jessica Webb; Meghana Kulkarni; Dana Dawson; Leena Sulaibeekh; Badri Chandrasekaran; Chiara Bucciarelli-Ducci; Ferdinando Pasquale; Martin R Cowie; William J McKenna; Mary N Sheppard; Perry M Elliott; Dudley J Pennell; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

4.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Steve R Ommen; Barry J Maron; Iacopo Olivotto; Martin S Maron; Franco Cecchi; Sandro Betocchi; Bernard J Gersh; Michael J Ackerman; Robert B McCully; Joseph A Dearani; Hartzell V Schaff; Gordon K Danielson; A Jamil Tajik; Rick A Nishimura
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

5.  Management of symptomatic hypertrophic obstructive cardiomyopathy--long-term results after surgical therapy.

Authors:  H D Schulte; K Borisov; E Gams; H Gramsch-Zabel; B Lösse; B Schwartzkopff
Journal:  Thorac Cardiovasc Surg       Date:  1999-08       Impact factor: 1.827

6.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Authors:  P M Elliott; J Poloniecki; S Dickie; S Sharma; L Monserrat; A Varnava; N G Mahon; W J McKenna
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

7.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.

Authors:  A Selcuk Adabag; Barry J Maron; Evan Appelbaum; Caitlin J Harrigan; Jacqueline L Buros; C Michael Gibson; John R Lesser; Constance A Hanna; James E Udelson; Warren J Manning; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

8.  Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.

Authors:  Deborah H Kwon; Randolph M Setser; Zoran B Popović; Maran Thamilarasan; Srikanth Sola; Paul Schoenhagen; Mario J Garcia; Scott D Flamm; Harry M Lever; Milind Y Desai
Journal:  Int J Cardiovasc Imaging       Date:  2008-01-19       Impact factor: 2.357

9.  Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy.

Authors:  J M ten Berg; M J Suttorp; P J Knaepen; S M Ernst; F E Vermeulen; W Jaarsma
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

10.  Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy.

Authors:  R C Robbins; E B Stinson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.